From September to December 2020, over 130 contributors from 16 countries across Europe2 came together in a bottom-up process3 to collect and discuss basic principles for successful patient involvement. They represented patient organizations, cancer research, participatory research, medical and healthcare professions, industry, research management, funding organizations and the policy-making level.
From September to December 2020, over 130 contributors from 16 countries across Europe2 came together in a bottom-up process3 to collect and discuss basic principles for successful patient involvement. They represented patient organizations, cancer research, participatory research, medical and healthcare professions, industry, research management, funding organizations and the policy-making level.
A síndrome de Lynch é uma das síndromes hereditárias de predisposição para cancro mais comuns. Trata-se de uma doença com transmissão autossómica dominante que surge após uma mutação germinativa num dos genes envolvidos na reparação do ADN: MLH1, MSH2, MSH6 e PMS2. Os indivíduos afetados apresentam um risco acrescido para cancro colorretal e outros cancros extracólicos, nomeadamente endométrio, ovário, estômago, intestino delgado, trato urinário, pâncreas e outros tumores cerebrais ou de glândulas.